The high levels of free fatty acids (FFAs) are the main manifestation of obesity
And Tirzepatide
The only manufacturer of semaglutide products, Novo Nordisk, stated that they do not provide the ingredient to these compounding pharmacies
Turning obesity into an iatrogenic disease?, Clinical Nutrition ESPEN, 74 , (103332), (2026)
Conclusion Constipation on GLP1 medications is common, persistent, and driven by the same slowed gut motility that helps reduce appetite
And then I stopped only because I had to pay for my tuition, and it aint cheap. Another recalled the work of staying on treatment during shortages, calling pharmacy after pharmacy in search of an available dose